Diphenylpyrazone
Diphenylpyrazone Brand names, Diphenylpyrazone Analogs
Diphenylpyrazone Brand Names Mixture
- No information avaliable
Diphenylpyrazone Chemical_Formula
C23H20N2O3S
Diphenylpyrazone RX_link
http://www.rxlist.com/cgi/generic3/sulfinpyrazone.htm
Diphenylpyrazone fda sheet
Diphenylpyrazone msds (material safety sheet)
Diphenylpyrazone Synthesis Reference
No information avaliable
Diphenylpyrazone Molecular Weight
404.483 g/mol
Diphenylpyrazone Melting Point
136-137 oC
Diphenylpyrazone H2O Solubility
31.2 mg/L
Diphenylpyrazone State
Solid
Diphenylpyrazone LogP
3.015
Diphenylpyrazone Dosage Forms
100-mg tablets and 200-mg capsules for oral administration
Diphenylpyrazone Indication
For the treatment of gout and gouty arthritis.
Diphenylpyrazone Pharmacology
Sulfinpyrazone's pharmacologic activity is the potentiation of the urinary excretion of uric acid. It is useful for reducing the blood urate levels in patients with chronic tophaceous gout and acute intermittent gout, and for promoting the resorption of tophi.
Diphenylpyrazone Absorption
No information avaliable
Diphenylpyrazone side effects and Toxicity
Symptoms of overdose include nausea, vomiting, diarrhea, epigastric pain, ataxia, labored respiration, convulsions, coma. Possible symptoms, seen after overdosage with other pyrazolone derivatives: anemia, jaundice, and ulceration.
Diphenylpyrazone Patient Information
No information avaliable
Diphenylpyrazone Organisms Affected
Humans and other mammals
